Validation of the Transferrin Receptor for Drug Targeting to Brain Capillary Endothelial CellsIn Vitro
- 1 April 2004
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 12 (3) , 145-150
- https://doi.org/10.1080/10611860410001701706
Abstract
Recently, we have shown that transferrin (Tf) is actively endocytosed by the Tf R on primary cultured bovine brain capillary endothelial cells (BCEC). The objective of this investigation is to determine whether the Tf R can facilitate endocytosis of a (protein) model drug, using Tf as a targeting vector. Secondly, the mechanism of endocytosis was investigated. Horseradish peroxidase (HRP, 40 kDa) was chosen as a model drug, since it normally does not cross the blood–brain barrier (BBB) and its concentration in biological media can be easily quantified. Tf-HRP conjugates (1:1) are actively and specifically endocytosed by BCEC in vitro in a concentration and time-dependent manner. At an applied concentration of 3 μg/ml, association (a combination of binding and endocytosis) of Tf-HRP reached equilibrium at a concentration of 2 ng/mg cell protein after 1 h of incubation at 37°C. This was approximately 3-fold higher compared to binding at 4°C (0.6 ng/mg cell protein). Association of Tf-HRP was compared to BSA-HRP. After 2 h of incubation at 37°C association levels were 5.2 and 2.5 ng/mg cell protein, for Tf-HRP and BSA-HRP, respectively. Under those conditions, association of Tf-HRP could be inhibited to approximately 30% of total association by an excess of non-conjugated Tf, but not with BSA, while association of BSA-HRP could be inhibited by both proteins. Furthermore, by using specific inhibitors of endocytotic processes, it was shown that association of Tf-HRP is via clathrin-coated vesicles. Association of Tf-HRP is inhibited by phenylarsine oxide (an inhibitor of clathrin-mediated endocytosis) to 0.4 ng/mg cell protein, but not by indomethacin, which inhibits formation of caveolae. Finally, following iron scavenging by deferoxamine mesylate (DFO, resulting in a higher Tf R expression) a 5-fold increase in association of Tf-HRP to 15.8 ng/mg cell protein was observed. In conclusion, the Tf R is potentially suitable for targeting of a (protein) cargo to the BBB and to facilitate its endocytosis by the BCEC.Keywords
This publication has 13 references indexed in Scilit:
- The Role of Drug Transporters at the Blood-Brain BarrierAnnual Review of Pharmacology and Toxicology, 2003
- Blood-Brain Barrier Drug Targeting Enables Neuroprotection in Brain Ischemia Following Delayed Intravenous Administration of NeurotrophinsPublished by Springer Nature ,2003
- Receptor-mediated internalization of [3H]–neurotensin in synaptosomal preparations from rat neostriatumNeuropharmacology, 2002
- Transferrin/transferrin receptor‐mediated drug deliveryMedicinal Research Reviews, 2002
- Drug and gene targeting to the brain with molecular trojan horsesNature Reviews Drug Discovery, 2002
- Induction of reduced endothelial permeability to horseradish peroxidase by factor(s) of human astrocytes and bladder carcinoma cells: detection in multi-well plate culture.Methods in Cell Science, 2001
- Antisense imaging of gene expression in the brain in vivoProceedings of the National Academy of Sciences, 2000
- A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain BarrierThe Journal of cell biology, 1997
- Blood to Brain and Brain to Blood Passage of Native Horseradish Peroxidase, Wheat Germ Agglutinin, and Albumin: Pharmacokinetic and Morphological AssessmentsJournal of Neurochemistry, 1994
- Characterization of the Scavenger Receptor on Bovine Cerebral Endothelial Cells In VitroJournal of Neurochemistry, 1993